VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹31 Cr | ₹30 Cr | ₹40 Cr | ₹11 Cr | ₹0.16 Cr |
What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹31 Cr |
Mar2024 | ₹30 Cr |
Mar2023 | ₹40 Cr |
Mar2022 | ₹11 Cr |
Mar2021 | ₹0.16 Cr |
How is Contingent Liabilities of VENUS REMEDIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹31 Cr | 0.51 | |
Mar2024 | ₹30 Cr | -23.13 | |
Mar2023 | ₹40 Cr | 272.42 | |
Mar2022 | ₹11 Cr | 6,423.93 | |
Mar2021 | ₹0.16 Cr | - |
Compare Contingent Liabilities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹616.1 Cr | -0.8% | -7.2% | 39.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,594.0 Cr | -2.1% | -5.8% | -6.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,722.0 Cr | 3.1% | -6.5% | 28.7% | Stock Analytics | |
CIPLA | ₹127,508.0 Cr | 2.2% | 3.2% | 1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,111.0 Cr | -1.7% | NA | 9.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,225.0 Cr | 1.4% | -1.1% | -7.6% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -0.8% |
-7.2% |
39.1% |
SENSEX | -2.2% |
-1.7% |
-1.2% |
You may also like the below Video Courses